UFP Technologies, Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
UFP Technologies, Inc. (UFPT) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of -$47.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-14.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2022-03-14
- UFP Technologies, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2021 was -$47.00K.
- UFP Technologies, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2018 was -$50.00K.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2021-12-31 | -$47.00K 10-K · filed 2022-03-14 |
| 2018-12-31 | -$50.00K 10-K · filed 2019-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |